(Q30671029)

English

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Gram-negative bacteria

0 references

United States of America

1 reference

based on heuristic

inferred from title

Clyde Thornsberry

3

object named as

Clyde Thornsberry

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

7

object named as

Daniel F Sahm

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Ian A Critchley

6

object named as

Ian A Critchley

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

author name string

James A Karlowsky

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Laurie J Kelly

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Mark E Jones

4

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Alan T Evangelista

5

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

21-31

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Susceptibility surveillance among gram-negative bacilli at a cancer center

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic resistance caused by gram-negative multidrug efflux pumps

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of bacterial resistance to quinolones.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Levofloxacin: a therapeutic review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial resistance to ciprofloxacin in Greece: results from the National Electronic Surveillance System. Greek Network for the Surveillance of Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900466-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(01)00466-6

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30671029&oldid=2106974787"